TD Asset Management Inc. Cuts Position in Encompass Health Co. (NYSE:EHC)

TD Asset Management Inc. reduced its stake in shares of Encompass Health Co. (NYSE:EHC) by 10.1% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,522,909 shares of the company’s stock after selling 171,467 shares during the quarter. TD Asset Management Inc.’s holdings in Encompass Health were worth $140,641,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in the stock. Vanguard Group Inc. lifted its position in shares of Encompass Health by 1.3% during the fourth quarter. Vanguard Group Inc. now owns 10,404,081 shares of the company’s stock valued at $960,817,000 after buying an additional 138,196 shares during the last quarter. State Street Corp lifted its position in Encompass Health by 0.7% during the third quarter. State Street Corp now owns 3,025,769 shares of the company’s stock valued at $292,410,000 after acquiring an additional 21,329 shares during the last quarter. Geode Capital Management LLC boosted its stake in Encompass Health by 1.2% in the third quarter. Geode Capital Management LLC now owns 1,673,610 shares of the company’s stock valued at $161,781,000 after acquiring an additional 20,547 shares in the last quarter. Copeland Capital Management LLC increased its position in shares of Encompass Health by 0.7% during the fourth quarter. Copeland Capital Management LLC now owns 1,293,098 shares of the company’s stock worth $119,418,000 after purchasing an additional 8,548 shares in the last quarter. Finally, Thrivent Financial for Lutherans boosted its position in shares of Encompass Health by 16.9% in the 4th quarter. Thrivent Financial for Lutherans now owns 888,827 shares of the company’s stock worth $82,083,000 after purchasing an additional 128,331 shares in the last quarter. Institutional investors own 97.25% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on EHC shares. StockNews.com upgraded Encompass Health from a “hold” rating to a “buy” rating in a research note on Saturday, February 15th. Barclays raised their price target on shares of Encompass Health from $116.00 to $118.00 and gave the stock an “overweight” rating in a report on Friday, February 7th. Royal Bank of Canada reissued an “outperform” rating and issued a $110.00 target price on shares of Encompass Health in a research report on Tuesday, February 11th. KeyCorp boosted their price target on Encompass Health from $117.00 to $120.00 and gave the company an “overweight” rating in a research note on Monday, February 10th. Finally, William Blair reaffirmed an “outperform” rating on shares of Encompass Health in a report on Friday, February 7th. Ten investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Buy” and an average target price of $107.67.

Encompass Health Stock Up 0.8 %

Shares of EHC opened at $100.71 on Wednesday. The company has a quick ratio of 1.04, a current ratio of 1.05 and a debt-to-equity ratio of 0.84. The stock has a fifty day simple moving average of $98.28 and a two-hundred day simple moving average of $97.26. Encompass Health Co. has a 52-week low of $76.11 and a 52-week high of $104.55. The company has a market capitalization of $10.14 billion, a PE ratio of 22.58, a price-to-earnings-growth ratio of 2.31 and a beta of 0.92.

Encompass Health (NYSE:EHC) last issued its quarterly earnings data on Thursday, February 6th. The company reported $1.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. As a group, equities analysts forecast that Encompass Health Co. will post 4.8 EPS for the current year.

Encompass Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be issued a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 0.68%. The ex-dividend date of this dividend is Tuesday, April 1st. Encompass Health’s dividend payout ratio (DPR) is 15.25%.

Insider Buying and Selling at Encompass Health

In other Encompass Health news, CAO Andrew L. Price sold 5,042 shares of the stock in a transaction that occurred on Thursday, February 13th. The shares were sold at an average price of $98.29, for a total transaction of $495,578.18. Following the sale, the chief accounting officer now directly owns 69,164 shares in the company, valued at $6,798,129.56. This represents a 6.79 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 2.10% of the stock is currently owned by corporate insiders.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.